These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7963582)

  • 1. C1q binding properties of monomer and polymer forms of mouse IgM mu-chain variants. Pro544Gly and Pro434Ala.
    Taylor B; Wright JF; Arya S; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1994 Dec; 153(11):5303-13. PubMed ID: 7963582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
    Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of amino acid residues in the C mu 3 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis.
    Arya S; Chen F; Spycher S; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1994 Feb; 152(3):1206-12. PubMed ID: 8301125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
    Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for IgM assembly and cytolytic activity. Effects of mutations in the oligosaccharide acceptor site at Asn402.
    Muraoka S; Shulman MJ
    J Immunol; 1989 Jan; 142(2):695-701. PubMed ID: 2911015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry and molecular genetics of C1q.
    Reid KB
    Behring Inst Mitt; 1989 Jul; (84):8-19. PubMed ID: 2679537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human C1q with IgG and IgM: revisited.
    Gadjeva MG; Rouseva MM; Zlatarova AS; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2008 Dec; 47(49):13093-102. PubMed ID: 19006321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR).
    Ghebrehiwet B
    J Immunol; 1986 Jul; 137(2):618-24. PubMed ID: 3487576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q.
    Roumenina LT; Kantardjiev AA; Atanasov BP; Waters P; Gadjeva M; Reid KB; Mantovani A; Kishore U; Kojouharova MS
    Biochemistry; 2005 Nov; 44(43):14097-109. PubMed ID: 16245926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of IgM structures involved in J chain incorporation.
    Wiersma EJ; Chen F; Bazin R; Collins C; Painter RH; Lemieux R; Shulman MJ
    J Immunol; 1997 Feb; 158(4):1719-26. PubMed ID: 9029108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the structure of polymeric IgM.
    Davis AC; Roux KH; Shulman MJ
    Eur J Immunol; 1988 Jul; 18(7):1001-8. PubMed ID: 3136022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the mouse mu H chain which prevent polymer assembly.
    Davis AC; Collins C; Yoshimura MI; D'Agostaro G; Shulman MJ
    J Immunol; 1989 Aug; 143(4):1352-7. PubMed ID: 2501393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation by cross-linked B cell-membrane IgM.
    Ohishi K; Kanoh M; Shinomiya H; Hitsumoto Y; Utsumi S
    J Immunol; 1995 Apr; 154(7):3173-9. PubMed ID: 7897206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain.
    Wright JF; Shulman MJ; Isenman DE; Painter RH
    J Biol Chem; 1988 Aug; 263(23):11221-6. PubMed ID: 3136155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the molecular mechanisms of classical complement activation.
    Kojouharova M; Reid K; Gadjeva M
    Mol Immunol; 2010 Aug; 47(13):2154-60. PubMed ID: 20542571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional affinity constants of the reaction between 125I-labelled C1q and C1q binders and their use in the measurement of plasma C1q concentrations.
    Hughes-Jones NC
    Immunology; 1977 Feb; 32(2):191-8. PubMed ID: 844894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of macromolecular interactions between complement subcomponents C1q, C1r, C1s, and immunoglobulin IgM by sedimentation analysis using the analytical ultracentrifuge.
    Poon PH; Schumaker VN
    J Biol Chem; 1991 Mar; 266(9):5723-7. PubMed ID: 2005109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.